The same anti-PD1 treatment in mouse models of CD8 + T cells’ depletion or TNF-guided neutralization induced an increase in the incidence of NASH-related HCC and tumor nodules (number and size). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.